Moreover, In IBD, excessive activation of the NF-κB pathway, triggered by TNF-α, leads to intestinal inflammation and dysfunction, but pretreatment with C3G inhibits this pathway and improves cellular redox status in caco-2 cells (179). This evidence concerns the gene NFKB1 and inflammatory bowel disease.